NPS PHARMACEUTICALS INC Revenue
NPS PHARMACEUTICALS INC reported Revenue of $66.69 million for the 3-month period ending 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2015-02-18
- NPS PHARMACEUTICALS INC revenues for the quarter ending 2014-12-31 was $66.69M, a 22.49% increase year-over-year.
- NPS PHARMACEUTICALS INC revenues for the quarter ending 2014-09-30 was $57.20M, a 45.91% increase year-over-year.
- NPS PHARMACEUTICALS INC revenues for the quarter ending 2014-06-30 was $56.13M, a 53.75% increase year-over-year.
- NPS PHARMACEUTICALS INC revenues for the quarter ending 2014-03-31 was $44.04M, a 73.15% increase year-over-year.
- NPS PHARMACEUTICALS INC revenues for fiscal 2014 was $224.06M, a 44.01% increase from fiscal 2013.
- NPS PHARMACEUTICALS INC revenues for fiscal 2013 was $155.59M, a 19.10% increase from fiscal 2012.
- NPS PHARMACEUTICALS INC revenues for fiscal 2012 was $130.64M, a 28.53% increase from fiscal 2011.
- NPS PHARMACEUTICALS INC revenues for fiscal 2011 was $101.64M, a 13.68% increase from fiscal 2010.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2014-12-31 | $66.69M 10-K · filed 2015-02-18 | $123.89M derived: sum of 2 quarters · filed 2015-02-18 | $180.02M derived: sum of 3 quarters · filed 2015-02-18 | $224.06M 10-K · filed 2015-02-18 |
| 2014-09-30 | $57.20M 10-K · filed 2015-02-18 | $113.33M derived: sum of 2 quarters · filed 2015-02-18 | $157.37M 10-Q · filed 2014-11-10 | $211.82M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-06-30 | $56.13M 10-K · filed 2015-02-18 | $100.17M 10-Q · filed 2014-08-06 | $154.62M derived: sum of 3 quarters · filed 2015-02-18 | $193.82M derived: sum of 4 quarters · filed 2015-02-18 |
| 2014-03-31 | $44.04M 10-K · filed 2015-02-18 | $98.49M derived: sum of 2 quarters · filed 2015-02-18 | $137.69M derived: sum of 3 quarters · filed 2015-02-18 | $174.20M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-12-31 | $54.45M 10-K · filed 2015-02-18 | $93.65M derived: sum of 2 quarters · filed 2015-02-18 | $130.16M derived: sum of 3 quarters · filed 2015-02-18 | $155.59M 10-K · filed 2015-02-18 |
| 2013-09-30 | $39.20M 10-K · filed 2015-02-18 | $75.71M derived: sum of 2 quarters · filed 2015-02-18 | $101.14M 10-Q · filed 2014-11-10 | $128.32M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | $36.51M 10-K · filed 2015-02-18 | $61.94M 10-Q · filed 2014-08-06 | $89.12M derived: sum of 3 quarters · filed 2015-02-18 | $116.14M derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $25.43M 10-K · filed 2015-02-18 | $52.62M derived: sum of 2 quarters · filed 2015-02-18 | $79.64M derived: sum of 3 quarters · filed 2015-02-18 | $133.15M derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | $27.18M 10-K · filed 2014-02-18 | $54.20M derived: sum of 2 quarters · filed 2014-02-18 | $107.72M derived: sum of 3 quarters · filed 2014-02-18 | $130.64M 10-K · filed 2015-02-18 |
| 2012-09-30 | $27.02M 10-K · filed 2014-02-18 | $80.54M derived: sum of 2 quarters · filed 2014-02-18 | $103.46M 10-Q · filed 2013-11-06 | $129.72M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $53.52M 10-K · filed 2014-02-18 | $76.44M 10-Q · filed 2013-08-08 | $102.70M derived: sum of 3 quarters · filed 2014-02-18 | $127.30M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $22.92M 10-K · filed 2014-02-18 | $49.18M derived: sum of 2 quarters · filed 2014-02-18 | $73.78M derived: sum of 3 quarters · filed 2014-02-18 | $100.99M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $26.26M 10-K · filed 2013-02-21 | $50.86M derived: sum of 2 quarters · filed 2013-02-21 | $78.07M derived: sum of 3 quarters · filed 2013-02-21 | $101.64M 10-K · filed 2014-02-18 |
| 2011-09-30 | $24.60M 10-K · filed 2013-02-21 | $51.81M derived: sum of 2 quarters · filed 2013-02-21 | $75.39M 10-Q · filed 2012-11-09 | $99.43M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-06-30 | $27.21M 10-K · filed 2013-02-21 | $50.79M 10-Q · filed 2012-08-01 | $74.83M derived: sum of 3 quarters · filed 2013-02-21 | $95.88M derived: sum of 4 quarters · filed 2013-02-21 |
| 2011-03-31 | $23.58M 10-K · filed 2013-02-21 | $47.62M derived: sum of 2 quarters · filed 2013-02-21 | $68.67M derived: sum of 3 quarters · filed 2013-02-21 | $92.69M derived: sum of 4 quarters · filed 2013-02-21 |
| 2010-12-31 | $24.04M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $45.10M derived: sum of 2 quarters · filed 2013-02-21 | $69.12M derived: sum of 3 quarters · filed 2013-02-21 | $89.41M 10-K · filed 2013-02-21 |
| 2010-09-30 | $21.05M 10-Q · filed 2011-11-03 | $45.07M derived: sum of 2 quarters · filed 2011-11-03 | $65.37M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | $24.02M 10-Q · filed 2011-08-02 | $44.32M 10-Q · filed 2011-08-02 | ||
| 2009-12-31 | $84.15M 10-K · filed 2012-02-15 |